Latest Bevacizumab Stories
CYRAMZA Now Approved in the U.S.
- End of Dose-Escalation Confirmed - VANCOUVER, British Columbia and MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- DelMar
CRANBURY, N.J., April 15, 2015 /PRNewswire/ -- Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing biosimilars, today announced that clinical development
DALLAS, April 10, 2015 /PRNewswire/ -- Lifescienceindustryresearch.com adds Global & USA Cancer Immunotherapy Market Analysis to 2020 a new research report in its store.
LONDON, April 8, 2015 /PRNewswire/ -- SummaryGBI Research, has released the pharma report -"Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline
LONDON, April 6, 2015 /PRNewswire/ -- Report DetailsAnalysis of revenues and R&D prospects for those eye drugs - you explore potentialsWhat's the future for treating disorders
New research report “Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons,
LONDON, April 1, 2015 /PRNewswire/ -- SummaryGBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics
LONDON, March 26, 2015 /PRNewswire/ -- Report Details Analysis of revenues and R&D prospects for those eye drugs - you explore potentials What's the future
PORTLAND, Oregon, March 25, 2015 /PRNewswire/ -- Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types,
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.